Skip to content

Travere Therapeutics, Inc. TVTX Prepaid & Other Current

Prepaid & Other Current at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$720.8M+12.1%
LQD
Liquidia CorporationLQDA
$7.61M+56.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$62.91M+77.9%
Arrowhead Research logo
Arrowhead ResearchARWR
$21.72M-8.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$66.05M+15.8%
Scholar Rock logo
Scholar RockSRRK
$35.34M+69.3%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%
Enterprise value$5.07B+65.5%
P/S9.6×-1.3×

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s prepaid & other current?
Travere Therapeutics, Inc. (TVTX) reported prepaid & other current of $34.35M in Q1 2026.
How has Travere Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Travere Therapeutics, Inc.'s prepaid & other current increased by 152.3% year-over-year, from $13.62M to $34.35M.
What is the long-term trend for Travere Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s prepaid & other current has grown at a 28.7% compound annual growth rate (CAGR), from $8.14M to $28.76M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.